Exenatide improves antioxidant capacity and reduces the expression of LDL receptors and PCSK9 in human insulin-secreting 1.1E7 cell line subjected to hyperglycemia and oxidative stress
Łukasz Bułdak
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Perfil de OrcidBuscar este autor en
, Estera Skudrzyk
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Perfil de OrcidBuscar este autor en
, Grzegorz Machnik
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Perfil de OrcidBuscar este autor en
, Aleksandra Bołdys
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Perfil de OrcidBuscar este autor en
, Rafał Jakub Bułdak
Institute of Medical Sciences, University of OpoleOpole, Poland
Perfil de OrcidBuscar este autor en
y Bogusław Okopień
Department of Internal Medicine and Clinical Pharmacology, School of Medicine in Katowice, Medical University of SilesiaKatowice, Poland
Perfil de OrcidBuscar este autor en
20 feb 2022
Acerca de este artículo